Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;25(4):261-267.
doi: 10.1159/000495321. Epub 2018 Dec 4.

Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches

Affiliations

Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches

Walter G Bradley et al. Ann Neurosci. 2018 Dec.

Abstract

Background: Amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's diseases are age-related neurodegenerative diseases. ALS is not a single entity but a syndrome with many different causes. In all 3 diseases, gene mutations account for only 10-15% of cases. Many environmental and lifestyle factors have been implicated as risk factors for ALS, though none have been proven to cause the disease. It is generally believed that ALS results from interactions between environmental risk factors and genetic predisposing factors. The advent of next-generation sequencing and recent advances in research into environmental risk factors offer the opportunity to investigate these interactions.

Summary: We propose a hypothesis to explain the syndrome of ALS based on the interaction of many individual environmental risk factors with many individual genetic predisposing factors. We hypothesize that there are many such combinations of individual, specific, genetic, and environmental factors, and that each combination can lead to the development of the syndrome of ALS. We also propose a hypothesis that explains the overlap between the age-related neurodegenerations and their genetic underpinnings. Age and duration of exposure are crucial factors in these age-related neurodegenerative diseases, and we consider how these may relate to gene-environment interactions.

Key messages: To date, genetic studies and environmental studies have investigated the causes of ALS separately. We argue that this univariate approach will not lead to discoveries of important gene-environment interactions. We propose new research approaches to investigating gene-environment interactions based on these hypotheses.

Keywords: Amyotrophic lateral sclerosis; Environmental risk factors; Gene-environment-time interactions; Genetic predisposition; Neurodegenerative diseases.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Hypothetical pathways by which gene-environment interactions might lead to different disease phenotypes. Upper two panels: Hypothesis 1 - hypothetical gene-environment interactions. Lower two panels: Hypothesis 2 - hypothetical disease-directing polymorphisms leading to different disease phenotypes. ALS, amyotrophic lateral sclerosis; AD, Alzheimer's disease; PD, Parkinson's disease; FTD, frontotemporal dementia.

Similar articles

Cited by

References

    1. Abrahao A, Abath Neto O, Kok F, et al. One family, one gene and three phenotypes: a novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Sci. 2016;368:352–358. - PubMed
    1. Nicholson AM, Rademakers R. What we know about TMEM106B in neurodegeneration. Acta Neuropathol. 2016;132:639–651. - PMC - PubMed
    1. Nicolas A, Kenna KP, Renton AE, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268–1283. e6. - PMC - PubMed
    1. Ali O. Genetics of type 2 diabetes. World j Diabetes. 2013;4:114–123. - PMC - PubMed
    1. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847–1850. - PubMed